ページ内を移動するためのリンクです。

Financial Highlights

*From FY2016, International Financial Reporting Standards (IFRS) is applied.Information for FY2015 is also presented in line with IFRS.

Key Results (Tables)Click to view graphs.

Consolidated Financial Data

   
FY2015 FY2016 FY2017 FY2018
Revenue JPY billion 1,427.4 1,195.5 1,240.0 1,292.0
YoY (16.2)% 3.7% 4.2%
Operating Profit JPY billion 148.9 101.1 104.2 108.3
YoY (32.1)% 3.0% 4.0%
Profit Attributable to Owners of the Company  JPY billion 102.0 92.6 112.5 82.5
YoY (9.2)% 21.5% (26.7)%
R&D
Expenses
JPY billion 202.7 168.8 175.6 216.1
YoY (16.7)% 4.0% 23.1%
   
FY2015 FY2016 FY2017 FY2018
Total Assets JPY billion 2,575.3 2,478.3 2,480.3 2,476.6
Equity JPY billion 1,727.4 1,738.4 1,822.0 1,732.3
Ratio of equity attributable to owners of the Company to total assets % 66.0 69.0 72.3 68.8

Revenue by Geographical Segment

  FY2018 (JPY billion) % of Net Sales
Japan 645.5 50.0
North America 347.1 26.9
Others 299.4 23.1
Total 1,292.0 100.0
Revenue to customers by market.

Revenue by Business Segment

  FY2018 (JPY billion) % of Net Sales
Pharmaceutical business 817.1 63.3
Nutraceutical business 338.6 26.2
Consumer products business 33.7 2.6
Other business 102.6 7.9
Total 1,292.0 100.0
Revenue to customers by market.

Key Management Indicators

 
FY2015 FY2016 FY2017 FY2018
ROE (%) 6.1% 5.4% 6.4% 4.7%
EPS (JPY) 188.2 170.8 207.6 152.2
Annual dividends per share (JPY) 100.0 100.0 100.0 100.0
Payout ratio (%) 53.1% 58.5% 48.2% 65.7%

Key Results (Graphs)Click to view tables.

  • Graph:Revenue

  • Graph:Operating Income

  • Graph:R&D Expenditure

  • Graph:Revenue by Geographical Segment

  • Sales by Business Segment